COMPANY
Keywords: immunology macular degeneration blindness
Location: Cambridge, MA · source · Jan 13, 2025
Profile checked Oct 10, 2026
Raises and investors new
Form D raises come from the company’s own SEC filing (last 2 years).
- InvestorListed in the portfolio of OrbiMed (captured Oct 12, 2026). portfolio page ↗
Jobs updated